ORALLY ADMINISTERED DOSAGE FORMS OF GABA ANALOG PRODRUGS HAVING REDUCED TOXICITY

摘要

The present invention provides an extended release oral dosage form of prodrugs of gabapentin and other GABA analogs, which dosage forms exhibit reduced toxicity. The dosage forms are particularly useful in administering those prodrugs of gabapentin and other GABA analogs that are metabolized to form an aldehyle. The dosage forms of the invention are useful for treating or preventing diseases and/or disorders for which the parent gabapentin or othe r GABA analog are known to be therapeutically effective.